These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 2230121)

  • 1. Binding of staphylococcal enterotoxin A to purified murine MHC class II molecules in supported lipid bilayers.
    Lee JM; Watts TH
    J Immunol; 1990 Nov; 145(10):3360-6. PubMed ID: 2230121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enterotoxin residues determining T-cell receptor V beta binding specificity.
    Irwin MJ; Hudson KR; Fraser JD; Gascoigne NR
    Nature; 1992 Oct; 359(6398):841-3. PubMed ID: 1436060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of toxic shock syndrome toxin-1 to murine major histocompatibility complex class II molecules.
    Scholl PR; Sekaly RP; Diez A; Glimcher LH; Geha RS
    Eur J Immunol; 1990 Sep; 20(9):1911-6. PubMed ID: 2209697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcal enterotoxin H displays unique MHC class II-binding properties.
    Nilsson H; Björk P; Dohlsten M; Antonsson P
    J Immunol; 1999 Dec; 163(12):6686-93. PubMed ID: 10586065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The crystal structure of staphylococcal enterotoxin H: implications for binding properties to MHC class II and TcR molecules.
    Hâkansson M; Petersson K; Nilsson H; Forsberg G; Björk P; Antonsson P; Svensson LA
    J Mol Biol; 2000 Sep; 302(3):527-37. PubMed ID: 10986116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutations in the MHC class II binding domains of staphylococcal enterotoxin A differentially affect T cell receptor Vbeta specificity.
    Newton DW; Dohlsten M; Olsson C; Segrén S; Lundin KE; Lando PA; Kalland T; Kotb M
    J Immunol; 1996 Nov; 157(9):3988-94. PubMed ID: 8892632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staphylococcal enterotoxin D is a promiscuous superantigen offering multiple modes of interactions with the MHC class II receptors.
    Al-Daccak R; Mehindate K; Damdoumi F; Etongué-Mayer P; Nilsson H; Antonsson P; Sundström M; Dohlsten M; Sékaly RP; Mourad W
    J Immunol; 1998 Jan; 160(1):225-32. PubMed ID: 9551975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of superantigen-induced T cell activation in the absence and the presence of MHC class II.
    Lando PA; Olsson C; Kalland T; Newton D; Kotb M; Dohlsten M
    J Immunol; 1996 Oct; 157(7):2857-63. PubMed ID: 8816390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A recombinant C-terminal fragment of staphylococcal enterotoxin A binds to human MHC class II products but does not activate T cells.
    Hedlund G; Dohlsten M; Herrmann T; Buell G; Lando PA; Segrén S; Schrimsher J; MacDonald HR; Sjögren HO; Kalland T
    J Immunol; 1991 Dec; 147(12):4082-5. PubMed ID: 1753087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutational analysis of the binding of staphylococcal enterotoxin D to the T cell receptor Vbeta chain and major histocompatibility complex class II.
    Li Y; Zhu X; Huang Y; Xiong H
    Immunol Lett; 2006 May; 105(1):55-60. PubMed ID: 16481046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody-targeted superantigens induce lysis of major histocompatibility complex class II-negative T-cell leukemia lines.
    Ihle J; Holzer U; Krull F; Dohlsten M; Kalland T; Niethammer D; Dannecker GE
    Cancer Res; 1995 Feb; 55(3):623-8. PubMed ID: 7530598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions between staphylococcal superantigens and MHC class II molecules.
    Labrecque N; Thibodeau J; Sékaly RP
    Semin Immunol; 1993 Feb; 5(1):23-32. PubMed ID: 8467091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of murine T cells by toxic shock syndrome toxin-1. The toxin-binding structures expressed on murine accessory cells are MHC class II molecules.
    Uchiyama T; Tadakuma T; Imanishi K; Araake M; Saito S; Yan XJ; Fujikawa H; Igarashi H; Yamaura N
    J Immunol; 1989 Nov; 143(10):3175-82. PubMed ID: 2509554
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of isotypes and allelic polymorphism on the binding of staphylococcal exotoxins to MHC class II molecules.
    Scholl PR; Diez A; Karr R; Sekaly RP; Trowsdale J; Geha RS
    J Immunol; 1990 Jan; 144(1):226-30. PubMed ID: 2404064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunopharmacology of the superantigen staphylococcal enterotoxin A in T-cell receptor V beta 3 transgenic mice.
    Dohlsten M; Björklund M; Sundstedt A; Hedlund G; Samson D; Kalland T
    Immunology; 1993 Aug; 79(4):520-7. PubMed ID: 7691731
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cross-linking of MHC class II molecules by staphylococcal enterotoxin A is essential for antigen-presenting cell and T cell activation.
    Tiedemann RE; Fraser JD
    J Immunol; 1996 Nov; 157(9):3958-66. PubMed ID: 8892628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of staphylococcal enterotoxin A to HLA-DR on B cell lines.
    Fischer H; Dohlsten M; Lindvall M; Sjögren HO; Carlsson R
    J Immunol; 1989 May; 142(9):3151-7. PubMed ID: 2785135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of binding domains on the superantigen, toxic shock syndrome-1, for class II MHC molecules.
    Soos JM; Russell JK; Jarpe MA; Pontzer CH; Johnson HM
    Biochem Biophys Res Commun; 1993 Mar; 191(3):1211-7. PubMed ID: 8466498
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular characterization and role in T cell activation of staphylococcal enterotoxin A binding to the HLA-DR alpha-chain.
    Thibodeau J; Dohlsten M; Cloutier I; Lavoie PM; Bjork P; Michel F; Léveillé C; Mourad W; Kalland T; Sékaly RP
    J Immunol; 1997 Apr; 158(8):3698-704. PubMed ID: 9103433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.